AstraZeneca says its vaccine is 79% effective in preventing symptomatic COVID-19
AstraZeneca released results from its United States phase three vaccine trial Monday, saying it’s 79% effective in preventing symptomatic COVID-19 and 100% effective at preventing severe disease and hospitalization.